Originally published In Press as doi:10.1074/jbc.M110369200 on February 25, 2002
J. Biol. Chem., Vol. 277, Issue 19, 17200-17208, May 10, 2002
Minor Alteration of Microtubule Dynamics Causes Loss of Tension
across Kinetochore Pairs and Activates the Spindle Checkpoint*
Jun
Zhou
§,
Dulal
Panda¶
,
Jaren W.
Landen§,
Leslie
Wilson¶, and
Harish C.
Joshi
§**
From the
Graduate Program in Biochemistry, Cell and
Developmental Biology and the § Department of Cell
Biology, Emory University School of Medicine, Atlanta, Georgia 30322 and the ¶ Department of Molecular, Cellular, and Developmental
Biology, University of California, Santa Barbara, California 93106
Received for publication, October 29, 2001, and in revised form, February 21, 2002
 |
ABSTRACT |
We have previously identified the opium alkaloid
noscapine as a microtubule interacting agent that binds
stoichiometrically to tubulin and alters its conformation. Here we show
that, unlike many other microtubule inhibitors, noscapine does not
significantly promote or inhibit microtubule polymerization. Instead,
it alters the steady-state dynamics of microtubule assembly, primarily
by increasing the amount of time that the microtubules spend in an attenuated (pause) state. Further studies reveal that even at high
concentrations, noscapine does not alter the tubulin polymer/monomer ratio in HeLa cells. Cells treated with noscapine arrest at mitosis with nearly normal bipolar spindles. Strikingly, although most of the
chromosomes in these cells are aligned at the metaphase plate, the rest
remain near the spindle poles, both of which exhibit loss of tension
across kinetochore pairs. Furthermore, levels of the spindle checkpoint
proteins Mad2, Bub1, and BubR1 decrease by 138-, 3.7-, and 3.9-fold,
respectively, at the kinetochore region upon chromosome alignment. Our
results thus suggest that an exquisite control of microtubule dynamics
is required for kinetochore tension generation and chromosome alignment
during mitosis. Our data also support the idea that Mad2 and Bub1/BubR1
respond to kinetochore-microtubule attachment and/or tension to
different degrees.
 |
INTRODUCTION |
Microtubules are cytoskeletal structures assembled from
/
-tubulin heterodimers that play an essential role in many
cellular processes, such as cell motility, organelle transport,
maintenance of cell polarity, and cell division (1). Microtubules are
intrinsically dynamic, in that they alternate abruptly and
stochastically between periods of growth and shortening, a phenomenon
termed "dynamic instability" (2, 3). A second dynamic behavior of
microtubules, termed "treadmilling," results from the net growth of
microtubules at one end and net shortening at the other end (4).
Several parameters have been used to characterize the dynamics of
microtubule assembly: growth rate, shortening rate, frequency of
transition from growth to shortening (catastrophe frequency (5)),
frequency of transition from shortening to growth or an attenuated
(pause) state (rescue frequency (5)), and the duration of the
attenuated state when neither microtubule growth nor shortening can be
detected (6). Overall microtubule dynamics due to dynamic instability is best described as "dynamicity," which measures the sum of
visually detectable tubulin dimer exchange per unit time at the ends of microtubules.
These dynamic properties are crucial for microtubules to carry out many
of their cellular functions such as reorientation of the microtubule
network when cells undergo migration or morphological changes and the
dramatic microtubule rearrangement at the onset of mitosis (7). Mitotic
microtubules are 10-100 times more dynamic than interphase
microtubules; they exchange their tubulin with the soluble tubulin pool
with half-times of ~15 s during mitosis as compared with 3 min to
several hours in interphase (8-11). The rapid microtubule dynamics in
mitosis is thought to be critical for both the morphogenesis and
activities of the bipolar spindle, which directs the alignment of
chromosomes at the metaphase plate and their final segregation into two
daughter cells.
Many microtubule interacting agents have been very useful in the study
of mitosis because they bind to microtubules and disrupt their normal
activities. One group of agents, such as paclitaxel, promotes
microtubule polymerization at high concentrations and bundles the
resulting stable microtubules. Another group, including colchicine,
nocodazole, and vinblastine, inhibits microtubule polymerization at
high concentrations and suppresses microtubule dynamics at low
concentrations (6). Although these different classes of microtubule
inhibitors act differently, they all block cell cycle progression at
prometaphase, thus preventing onset of the metaphase-anaphase
transition. It is generally believed that these agents cause spindle
damage or suppress spindle dynamics, consequently activating the
spindle checkpoint to block cells at mitosis (6, 12). In its role as a
molecular safeguard, the spindle checkpoint might be able to sense even
minor errors in spindle function. Consequently, drugs that alter
spindle dynamics without changing microtubule polymer mass would be
powerful tools for studying the roles of microtubule dynamics in
mitosis and for refining the mechanisms for spindle checkpoint activation.
We have previously found that the opium alkaloid noscapine binds
stoichiometrically to tubulin, alters the conformation of tubulin, and
arrests mammalian cells at mitosis without causing gross deformations
of cellular microtubules (13). In this study we demonstrate that
noscapine suppresses the steady-state dynamics of microtubule assembly
without significantly affecting microtubule polymerization in
vitro or in tissue culture cells even at high concentrations. Our
data also show clearly that minor alteration of microtubule dynamics by
noscapine causes failure of chromosome congression and loss of
tension across sister kinetochores and activates the spindle
checkpoint. These findings not only provide important insight into the
mechanism by which noscapine blocks mitotic progression but also shed
light on the molecular basis of how the kinetochore tension is
generated and how the spindle checkpoint proteins respond to
microtubule attachment and/or tension.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Bovine brain microtubule proteins were isolated
without glycerol by three cycles of polymerization and
depolymerization. Tubulin was purified from the microtubule proteins by
phosphocellulose chromatography as described previously (14). The
tubulin solution was quickly frozen as drops in liquid nitrogen and
stored at
70 °C until use. Protein concentration was determined by
the method of Bradford (15) using bovine serum albumin
(BSA)1 as the standard.
Noscapine (97% purity) was purchased from Aldrich. The
noscapine stock solution was prepared at 100 mM in dimethyl sulfoxide (Me2SO) and stored at
20 °C until use.
Paclitaxel, nocodazole, and vinblastine were all from Sigma and
dissolved in Me2SO as 10 mM stock solutions.
Cell Culture--
HeLa cells were maintained in Dulbecco's
modified Eagle's medium (Invitrogen) supplemented with 10% fetal
bovine serum (Invitrogen) at 37 °C in a 5% CO2, 95%
air atmosphere. Cells were grown as monolayers in tissue culture plates
or on glass coverslips.
In Vitro Assembly of Tubulin Subunits--
Spectrophotometer
cuvettes (0.4-cm path length) held a solution consisting of microtubule
assembly buffer (100 mM Pipes, 2 mM EGTA, 1 mM MgCl2, 1 mM GTP, pH 6.8) and 1, 10, or 100 µM noscapine, 10 µM paclitaxel,
10 µM nocodazole, or the solvent Me2SO. The cuvettes were kept at room temperature before the addition of 10 µM purified tubulin and shifted to 37 °C in a
temperature-controlled Ultrospec 3000 spectrophotometer
(Amersham Biosciences). The assembly was monitored by measuring the
changes in absorbance (350 nm) at 0.5-min intervals.
Measurement of Microtubule Dynamics--
Bovine brain tubulin
was mixed with sea urchin flagellar axoneme seeds and polymerized in
PMME buffer (87 mM Pipes, 36 mM MES, 1.8 mM MgCl2, 1 mM EGTA, pH 6.8)
containing 1 mM GTP in the absence or presence of different
concentrations of noscapine. The seed concentration was adjusted to
achieve 3-6 seeds/microscopic field. After 35 min of
incubation, samples of microtubule suspensions (2.5 µl) were prepared
for videomicroscopy, and the dynamics of individual microtubules were
recorded at 37 °C as described previously (16, 17). Microtubules
were observed for a maximum of 45 min after reaching steady state.
Under the experimental conditions used, microtubule growth occurred
predominantly at the plus ends of the seeds as determined by the growth
rates, the number of microtubules that grew, and the relative lengths
of the microtubules at the opposite ends of the seeds (5, 14,
16-19).
Microtubule length changes were analyzed as described previously (16,
17). We considered the microtubule to be in a growing phase if the
microtubule increased in length by >0.2 µm at a rate of >0.15
µm/min, and in a shortening phase if the microtubule shortened in
length by >0.2 µm at a rate of >0.3 µm/min. Length changes equal
to or less than 0.2 µm over the duration of 6 data points were
considered as attenuation (pause) phases. We used the same tubulin
preparation for all experiments, and an average of 25-30 microtubules
was measured for each experimental condition. The catastrophe frequency
was calculated by dividing the number of catastrophes by the sum of the
total time spent in the growing plus attenuated state for all
microtubules for a particular condition. Similarly, the rescue
frequency was calculated by dividing the total number of rescue events
by the total time spent shortening for all microtubules for a
particular condition.
Preparation of Polymeric (Cytoskeletal) and Monomeric (Soluble)
Tubulin--
Cells were washed, and soluble proteins were then
extracted under conditions that prevent microtubule depolymerization
(0.1% Triton X-100, 0.1 M MES, pH 6.75, 1 mM MgSO4, 2 mM EGTA, 4 M glycerol) (20). The remaining cytoskeletal fraction in
the culture dish was dissolved in 0.5 ml of 0.5% SDS in 25 mM Tris (pH 6.8). Total protein concentration was then
determined in each fraction by BCA reagents (Pierce). Equivalent
amounts for each treatment group were loaded on the gel and stained
with Coomassie Blue. A duplicate gel was then transferred for Western
blot analysis using monoclonal anti-
-tubulin antibody (Sigma).
Western Blot Analysis--
Proteins extracted from mammalian
cells were analyzed by polyacrylamide gel electrophoresis as described
(21), and the protein bands were electrophoretically transferred onto
polyvinylidene difluoride membranes (Millipore, Bedford, MA). The
membranes were incubated first with primary antibodies and then with
horseradish peroxidase-labeled secondary antibodies. Specific proteins
were visualized using enhanced chemiluminescence following
manufacturer's instructions (Amersham Biosciences). The relative
protein levels were determined by densitometric analysis using a Lynx
video densitometer (Biological Vision Inc., San Mateo, CA).
Flow Cytometric Analysis--
The flow cytometric evaluation of
the cell cycle status was performed as previously described (13).
Briefly, 2 × 106 HeLa cells were centrifuged, washed
twice with ice-cold phosphate-buffered saline (PBS), and fixed in 70%
ethanol. Tubes containing the cell pellets were stored at
20 °C
for at least 24 h. After this, the cells were centrifuged at
1000 × g for 10 min, and the supernatant was
discarded. The pellets were resuspended in 30 µl of phosphate/citrate buffer (0.2 M Na2HPO4/0.1
M citric acid, pH 7.5) at room temperature for 30 min.
Cells were then washed with 5 ml of PBS and incubated with propidium
iodide (20 µg/ml)/RNase A (20 µg/ml) in PBS for 30 min. Samples
were analyzed on a Coulter Elite flow cytometer (Beckman Coulter, Inc.,
Fullerton, CA).
Immunofluorescence Microscopy--
To visualize microtubules,
HeLa cells grown on glass coverslips were fixed with cold (
20 °C)
methanol for 5 min and then washed with PBS for 5 min. Nonspecific
sites were blocked by incubating with 100 µl of 2% BSA in PBS at
37 °C for 15 min. A mouse monoclonal antibody against
-tubulin
(DM1A, Sigma) was diluted 1:500 in 2% BSA in PBS and incubated (100 µl) with the coverslips at 37oC for 2 h. Cells
were then washed with 2% BSA/PBS for 10 min at room temperature before
incubating with a 1:100 dilution of a fluorescein-labeled donkey
anti-mouse IgG antibody (Jackson ImmunoResearch, Inc., West Grove, PA)
at 37 °C for 1 h. Coverslips were then rinsed with 2% BSA/PBS
for 10 min and incubated with propidium iodide for another 10 min at
room temperature before they were mounted with AquaMount (Lerner
Laboratories, Pittsburgh, PA) containing 0.01%
1,4-diazobicyclo(2,2,2)octane (DABCO, Sigma). Cells were examined with
a Zeiss Axiovert 135 fluorescence microscope using a 100×/1.3 oil lens
(Plan-Neofluar, Carl Zeiss, Inc., Thornwood, NY).
To visualize the spindle checkpoint proteins Mad2, Bub1, and BubR1,
HeLa cells were grown on poly-L-lysine-coated glass
coverslips and fixed with 1% paraformaldehyde/PBS for 20 min at room
temperature. Coverslips were then washed with PBS for 5 min,
permeabilized with 0.2% Triton X-100/PBS for 2 min, and washed for
another 5 min with PBS before they were processed for incubation with
primary and secondary antibodies, stained with propidium iodide, and
examined microscopically as described above. Rabbit polyclonal
anti-Mad2 antibody was obtained from Dr. E. D. Salmon (University of
North Carolina) and used at a 1:200 dilution. Rabbit polyclonal
anti-Bub1 and mouse monoclonal anti-BubR1 antibodies were from Dr.
T. J. Yen (Fox Chase Cancer Institute) and used at 1:1000 and 1:1200 dilutions, respectively. Fluorescein-labeled donkey anti-rabbit and
donkey anti-mouse IgG antibodies were from Jackson ImmunoResearch and
used at 1:100 dilutions.
Analysis of the Integrated Intensity of Kinetochore
Fluorescence--
The integrated intensity of immunofluorescently
stained kinetochores was measured using a method developed initially by
King et al. (22) and described in detail by Hoffman et
al. (23). All images were taken from the stacks of 12-bit confocal
images using the LSM510 imaging software (Carl Zeiss). Images did not require deconvolution because of the sufficient focal depth of the
numerical aperture of the 100×/1.4 Plan-Neofluar objective to capture
most, if not all, kinetochore fluorescence intensity (22, 23). Two
computer-generated squares, called the inner and outer squares,
respectively, were centered outside of each kinetochore (Fig.
9A). They represented 38 × 38 and 48 × 48 pixels2, respectively. The 38 × 38-pixel region was
designated as the 0.76 × 0.76 µm2-area, which was
large enough to contain the majority of kinetochore fluorescence in
HeLa cells. To correct for the background fluorescence, we chose to
measure the fluorescence intensity in a square region 5 pixels away
from the periphery of the inner square. The total integrated
fluorescence counts within each square were recorded, and the data were
transferred to Microsoft Excel. The measured fluorescence of the
38 × 38-pixel region included the kinetochore fluorescence and
the background fluorescence, whereas the fluorescence within the region
between perimeter of outer and inner squares included mostly the
background fluorescence. This allowed us to correct for the real
kinetochore fluorescence (see the diagram and
equation in Fig. 9A).
Measurement of Sister Kinetochore Distance--
Cells grown on
glass coverslips were treated with 20 µM noscapine or 6.7 nM vinblastine for 4 h and then fixed with 2%
paraformaldehyde/PBS, permeabilized with 0.2% Triton X-100/PBS, and
processed with primary and secondary antibodies as described above.
Anti-human centromere antibodies (hACA) were kindly provided by Dr.
K. F. Sullivan (Scripps Research Institute) and used at 1:100 dilution
to visualized centromeres. Monoclonal antibodies against
-tubulin
(DM1A, Sigma) were also used to identify mitotic figures.
Fluorescein-labeled donkey anti-human and rhodamine-labeled donkey
anti-mouse IgG antibodies were from Jackson ImmunoResearch and used at
1:100 dilutions. The center-to-center distances between sister
kinetochores were measured from 12-bit confocal image stacks. When
sister kinetochores were in the same focal plane, the real
inter-kinetochore distance (d) equals the measured distance
between the two sister kinetochores (y). When sister
kinetochores were not in the same focal plane, the inter-kinetochore distance (d) was corrected by triangulation of the measured
distance (y) and the z axis distance
(z) between two focal planes containing the brightest
staining for each of the two sister kinetochores (Ref. 24; also see the
diagram and equation in Fig. 6B).
 |
RESULTS |
Effects of Noscapine on the Assembly of Tubulin Subunits--
We
have previously shown that noscapine binds to tubulin with a
stoichiometry of 1 (0.95 ± 0.02) noscapine molecule/tubulin dimer
and induces conformational changes in tubulin upon binding (13). In
addition, when incubated with cultured mammalian cells, noscapine
significantly increases the mitotic index and blocks cell
proliferation, indicating an arrest in mitosis (13). It is conceivable
that the mitotic arrest caused by noscapine may result from the
suppression of microtubule dynamics and not the action of noscapine on
the extent of tubulin polymerization. To test this hypothesis, we first
examined the effect of noscapine on the assembly of tubulin subunits
into microtubules in vitro by measuring changes in the
turbidity produced upon tubulin polymerization in the presence of
noscapine. 1 µM noscapine did not have a detectable effect on tubulin assembly, showing an absorbance curve
overlapping that of the solvent control (Fig.
1). At concentrations of 10 and 100 µM, noscapine only slightly increased the extent of
microtubule polymerization. In contrast, 10 µM paclitaxel
strongly promoted microtubule polymerization, and 10 µM
nocodazole strongly inhibited microtubule polymerization (Fig.
1).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 1.
Noscapine does not significantly affect the
assembly of tubulin into microtubules in vitro.
The effects of different concentrations of noscapine on tubulin polymer
formation were measured by light scattering, reflected as the
absorbance at 350 nm wavelength. For purposes of comparison, 10 µM paclitaxel and nocodazole were also used. Note that
the A350 scattering by the polymerization of
tubulin over time in the presence of 1 µM noscapine
overlapped with that of the control, indicating that 1 µM
noscapine did not affect the rate or extent of microtubule
assembly.
|
|
Effects of Noscapine on Microtubule Dynamic Instability
at Steady State--
We next studied the effect of noscapine on
the steady-state dynamic instability behavior of microtubules assembled
in vitro from purified tubulin by video microscopy.
Microtubule growth occurred predominantly at the plus ends of the seeds
as determined by the growth rates, the number of microtubules that
grew, and the relative lengths of the microtubules at the opposite ends of the seeds. Several life history traces of microtubule length changes
in the absence of noscapine are shown in Fig.
2A. As expected, microtubules
alternated between phases of growing and shortening, and also spent a
small fraction of time in an attenuated state, neither growing nor
shortening to a detectable extent. The addition of 20 µM
noscapine suppressed microtubule dynamics (Fig. 2B). It
reduced the growing and shortening rates and increased the percentage
of time that the microtubules spent in the attenuated state.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 2.
Life history plots of representative in
vitro assembled microtubules at their plus ends at steady
state in the absence (A) or presence of 20 µM noscapine (B).
The lengths of individual microtubules were measured from real-time
videotape recordings as described under "Experimental
Procedures."
|
|
The actions of noscapine on the individual dynamic instability
parameters at steady state were determined quantitatively (Table I). Noscapine slightly suppressed the
growing rate of microtubule plus ends. For example, the mean growing
rate in the absence of noscapine was 0.92 µm/min, and the addition of
20 µM noscapine reduced the growing rate to 0.60 µm/min. Even at the high concentration of 50 µM,
noscapine reduced the mean growing rate by only 42.4%. Similar to its
effects on microtubule growth, noscapine also slightly affected the
rate and extent of microtubule shortening (Table I). For example, in
the presence of 20 and 50 µM noscapine, the shortening
rate was reduced by 21.6 and 24.3%, respectively. In addition,
noscapine reduced the percentage of time microtubules spent in the
shortening phase (Table I).
Microtubules, both in vitro and in cells, spend a
considerable fraction of time in an attenuated (pause) phase at or near steady state (6, 14, 19, 25). Strikingly, noscapine increased the
percentage of time that the microtubules spent in the attenuated state
(Table I). For example, in the presence of 50 µM
noscapine, microtubules spent 12.7% of the time in the attenuated
state, which is a 1.9-fold increase compared with microtubules
in the absence of noscapine.
The transition frequencies among the growing, shortening,
and attenuated states are considered important in the regulation of
microtubule dynamics in cells (11, 26). Noscapine strongly decreased
the catastrophe frequency and increased the rescue frequency (Table I).
Dynamicity is a parameter that reflects the overall dynamics of the
microtubules (the total detectable tubulin dimer addition and loss at a
microtubule end (6, 14, 25)). As shown in Table I, 20 and 50 µM noscapine suppressed microtubule dynamicity by 62.5 and 62.1%, respectively.
Noscapine Does Not Change Tubulin Polymer/Monomer Ratio in
Cells--
The moderate suppression effects of noscapine on
microtubule dynamics in vitro and its subtle effect on
microtubule polymerization predicted that unlike paclitaxel,
nocodazole, or vinblastine, noscapine might not significantly change
the tubulin polymer/monomer ratio in vivo at high
concentrations. To test this hypothesis, we prepared cell extracts that
contain cytoskeletal (polymeric) and soluble (monomeric) tubulin,
respectively, from HeLa cells treated with different concentrations of
noscapine and performed a quantitative Western blot analysis as shown
in Fig. 3. The percentage of polymeric
tubulin in cells treated with 1, 10, and 100 µM noscapine was 58.3, 59.2, and 59.2%, respectively. These values are very similar
to that in control cells that were treated with the equivalent amount
of the solvent Me2SO (59.4%). In contrast, as expected, for cells treated with 10 µM paclitaxel, 99.6% of
tubulin was in the polymeric form, and for those cells treated with 10 µM nocodazole, only 12.1% of the tubulin was polymeric.
Thus, although paclitaxel increased tubulin in the polymeric fraction
and nocodazole increased tubulin in the monomeric fraction, noscapine
induced no measurable increase or decrease of tubulin in the polymeric or monomeric fractions.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of noscapine on the tubulin
polymer/monomer ratio in HeLa cells. A, Coomassie Blue
staining of the proteins in cell extracts containing polymeric
(P) or monomeric/soluble (S) tubulin. Cells were
treated with 1, 10, 100 µM noscapine, 10 µM
paclitaxel, 10 µM nocodazole, or the equivalent amount of
the solvent Me2SO for 4 h, and cell extracts were then
isolated as described (20). B and C, Western blot
analysis showing polymeric and monomeric tubulin in the cells
described in A. In C, cell extracts were loaded
at a 1.25-fold serial dilution starting from 30 µg of protein to
ensure measurement in the linear range of detection. D,
quantitation by densitometry of the fraction of polymeric
tubulin in cells treated under different drug conditions. Although
paclitaxel increases tubulin in the polymeric fraction and nocodazole
increases tubulin in the soluble fraction, noscapine causes no
detectable changes in polymeric or soluble tubulin fractions.
|
|
Chromosome Alignment Failure in Noscapine-arrested Mitotic
Cells--
We have previously found that, similar to other microtubule
interacting agents, noscapine arrests mammalian cells at mitosis (13).
However, unlike many known microtubule inhibitors, noscapine does not
cause gross deformations of cellular microtubules. This discovery led
us to explore the effect of noscapine during mitosis. At low
concentrations (e.g. 1 µM), noscapine could
not arrest mitosis even after a 36-h treatment. 10 µM
noscapine did have an effect on mitotic arrest, but the efficiency was
quite low (17.6% for a 24-h treatment). However, when noscapine
concentration was increased up to 20 µM, its effect on
mitotic arrest was much clearer (70.2% for a 24-h treatment). As shown
in Fig. 4A, following a 12-h
treatment with 20 µM noscapine, many human HeLa cells
were arrested at mitosis with condensed chromosomes. This arrest was accompanied by an increased fraction of cells with 4N DNA content, as
revealed by a fluorescence-activated cell sorting assay (Fig. 4B). Interestingly, mitotic arrested cells resulting from
treatment with 20 or even 100 µM noscapine formed nearly
normal bipolar spindles (Figs. 4 and 5).
Higher concentrations of noscapine were not applicable because of
the low solubility of noscapine in the culture medium.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 4.
Noscapine arrests HeLa cells at
mitosis. A, immunofluorescence micrographs of
microtubule arrays and DNA in HeLa cells untreated or treated with 20 µM noscapine for 12 h. In the set of panels
showing noscapine treatment, the lens was focused on mitotic cells to
highlight the chromosome alignment failure caused by noscapine. As a
result, the flat interphase cells were slightly out of focus.
Bars, 10 µm. B, flow cytometric analysis of DNA
content in HeLa cells untreated (left) or treated with
noscapine (right). Noscapine treatment resulted in a clear
increase in the percentage of cells with a duplicated complement of DNA
(4N).
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Effects of gradient concentrations of
noscapine on the morphology of the mitotic spindle in HeLa cells.
In normal metaphase all chromosomes are aligned at the metaphase plate
of a bipolar spindle. 6.7 nM vinblastine-arrested cells
have bipolar mitotic spindles; most of these cells show completion of
chromosome alignment (72.7%), and a small fraction of them show
incomplete alignment (14.5%). 1 µM noscapine does not
have a detectable effect on mitotic arrest. Mitotic cells arrested by
10, 20, or 100 µM noscapine all have nearly normal
bipolar spindles although most of the chromosomes in these cells are
aligned at the metaphase plate, many remain near the spindle poles.
Bar, 10 µm.
|
|
In addition, we found that in noscapine-arrested HeLa cells, although
most of the chromosomes were aligned at the equatorial metaphase plate,
the remaining chromosomes were present near the spindle poles (Fig. 5).
This action of noscapine is not only similar to when microtubule
dynamics are suppressed by nanomolar concentrations of vinblastine and
paclitaxel (Ref. 6, also see Fig. 5) but also to when the kinetochore
motor CENP-E is lacking (27-30). These results suggested that
chromosome congression and subsequent alignment at the metaphase plate
might require an exquisite control of microtubule dynamics. Noscapine,
although causing only a slight alteration of microtubule dynamics
in vitro, appears to cause a severe disruption of
microtubule-mediated events. At present we cannot rule out the
possibility that this might be due to the inhibition of the function of
some other proteins, such as CENP-E, in vivo by
noscapine in some unknown way.
Noscapine Causes Loss of Tension across Kinetochore Pairs--
It
has generally been believed that the attachment between kinetochores of
chromosomes and the plus ends of microtubules is highly dynamic, in
that tubulin subunits can assemble and disassemble at the kinetochore
region (31). Physical tension is generated across kinetochore pairs
following microtubule attachment to kinetochores. The amount of tension
generated between kinetochore pairs is probably regulated by the
combined action of microtubule dynamics and microtubule motors within
the vicinity of kinetochores (32, 33). Noscapine, which dampens the
dynamic growth and shortening of microtubules, could impact upon the
tension between kinetochore pairs and/or the attachment between
kinetochores and microtubules. Either of these effects might in turn
activate the spindle checkpoint, thereby blocking mitotic progression.
The sister kinetochore distance is a good measure of the tension
exerted upon kinetochore pairs by attached microtubules (33-35). Immunofluorescent staining of sister centromeres followed by confocal microscopy allowed us to clearly resolve the kinetochores of sister chromatids (see insets in Fig.
6A). To examine the effect of
noscapine on the kinetochore tension, we measured the distance between
sister kinetochores in mitotic cells treated or untreated with 20 µM noscapine (Fig. 6B). We found that the
distance between kinetochore pairs in noscapine-treated mitotic cells
was 1.35 ± 0.34 µm on average, which was 30% less than that in
control cells, indicating the reduction of tension by noscapine
treatment. In addition, the sister kinetochore distance of chromosomes
near the spindle poles (group II) was slightly less than
that of chromosomes aligned at the equatorial metaphase plate
(group I). The 30% reduction of kinetochore tension by
noscapine treatment was comparable with those obtained in low dose
vinblastine-treated cells (31% reduction) and in cells in
which kinetochore tension was completely eliminated by high dose
nocodazole (34% reduction) (Fig. 6B). Our results were also
in agreement with those reported earlier in cells treated with
paclitaxel, vinblastine, or nocodazole (24, 35, 36). Our preliminary
electron microscopic analysis showed that the number of kinetochore
microtubules of the aligned chromosomes was also reduced by noscapine
treatment.2 This indicates
that the loss of tension by noscapine treatment can be attributed not
only to the suppression of microtubule dynamics but to fewer
microtubules attached per kinetochore.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 6.
Elimination of kinetochore tension by
noscapine treatment. A, double color immunofluorescent
images showing centromeres (green) and microtubules
(red) in metaphase HeLa cells. Cells treated with 20 µM noscapine are compared with those untreated
(Control) or treated with 6.7 nM vinblastine or
20 µM nocodazole. Insets are magnified images
of representative sister kinetochores from which the sister kinetochore
distance is measured. In the panel showing noscapine treatment,
two insets represent kinetochore pairs of aligned
(left inset) and unaligned chromosomes (right
inset), respectively. Note that centromeres in the untreated
metaphase cells were distinctly elongated; they were highly symmetric
structures around the metaphase plate in typical vinblastine-arrested
metaphase cells. In nocodazole-treated cells, microtubules were
completely depolymerized, and centromeres were scattered in the cell.
In contrast, in noscapine-arrested metaphase cells centromeres were
either around the metaphase plate or near spindle poles.
Bar, 10 µm. B, noscapine treatment caused a
reduction of sister kinetochore distance, indicating loss of tension at
kinetochores. Sister kinetochore distances were measured as diagrammed
in the figure and described under "Experimental Procedures." Note
that in noscapine-arrested cells, the sister kinetochore distance of
chromosomes aligned at the center (group I) was larger than
that of chromosomes near the spindle poles (group II), but
both of them were comparable with that in vinblastine-arrested cells
and in nocodazole-treated cells that lacked microtubules.
|
|
Activation of the Spindle Checkpoint by Noscapine
Treatment--
We next investigated the spindle checkpoint status in
noscapine-arrested cells by examining the cellular localization
patterns of three checkpoint proteins, Mad2, Bub1, and BubR1. All of
these proteins are essential for spindle checkpoint control in human cells (28, 37-40). In prometaphase Mad2 is localized to the
kinetochore region, whereas in metaphase it is no longer detectable at
kinetochores (Ref. 41; also see Fig. 7,
Control). Strikingly, we observed that in noscapine-arrested
mitotic cells, Mad2 was present at the kinetochores on chromosomes that
were near the spindle poles but was not detectable on chromosomes
aligned at the metaphase plate (Fig. 7). In contrast, Bub1 and BubR1
were localized to the kinetochores on both groups of chromosomes (Fig.
8). Similar localization patterns of Mad2
and Bub1/BubR1 were found in low dose vinblastine-arrested mitotic
cells (Figs. 7 and 8). Nevertheless, in cells treated with either
noscapine or vinblastine, the kinetochores on aligned chromosomes
showed a slight reduction in Bub1 and BubR1 staining compared with
those unaligned, although the difference was not as dramatic as seen
for Mad2.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 7.
Localization patterns of the spindle
checkpoint protein Mad2 within the vicinity of kinetochores. Cells
treated with 20 µM noscapine were compared with control
metaphase cells and 6.7 nM vinblastine-arrested mitotic
cells. Mad2 and DNA were stained and visualized as described under
"Experimental Procedures." Note that in mitotic cells arrested by
noscapine or vinblastine, Mad2 was recruited to the kinetochores on
chromosomes near the spindle poles but was not found on chromosomes
aligned at the metaphase plate. Bar, 10 µm.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 8.
Double color staining of Bub1/BubR1
(green) and DNA (red) showing the
localization patterns of Bub1 and BubR1 within the vicinity of
kinetochores. Cells were treated as described in the legend for
Fig. 7 and stained and visualized as described under "Experimental
Procedures." Bar, 10 µm.
|
|
We then used quantitative immunofluorescence microscopy to further
compare the difference among these checkpoint proteins at kinetochores
on aligned and unaligned chromosomes. Clearly, the fluorescence
intensity of Mad2 at kinetochores on unaligned chromosomes was 138-fold
higher than that on aligned chromosomes in cells treated with noscapine
(Table II and Fig. 9). In these cells,
the levels of Bub1 and BubR1 at kinetochores decreased by 3.7- and
3.9-fold, respectively, upon metaphase alignment. As a comparison, in
6.7 nM vinblastine-treated cells, the intensity of Mad2,
Bub1, and BubR1 decreased by 152-, 4.0-, and 4.3-fold, respectively,
upon chromosome alignment (Table II and Fig.
9). These values were in excellent
agreement with those reported by Hoffman et al. (23) for the
changes of Mad2 and BubR1 intensity in PtK1 cells. In addition, the
3-4-fold reductions of Bub1 and BubR1 staining at kinetochores of
vinblastine- and noscapine-treated cells were also similar to the
reduction seen for these proteins at aligned kinetochores of
non-drug-treated cells. Our data thus support the idea that Mad2 and
Bub1/BubR1 respond to the kinetochore-microtubule attachment and/or
tension to different degrees.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 9.
Quantitation of the fluorescence intensity of
individual kinetochores. A, diagram showing the method
used to measure kinetochore fluorescence intensity as described under
"Experimental Procedures." B, quantitative analysis of
the changes in kinetochore fluorescence of unaligned chromosomes
compared with aligned chromosomes. Kinetochores were stained with
antibodies against Mad2, Bub1, and BubR1, respectively. Relative
Fluorescence Intensity refers to the values relative to those for
kinetochores on aligned chromosomes, as summarized in Table II.
|
|
 |
DISCUSSION |
Noscapine is a novel microtubule interacting agent that arrests
mitosis in dividing mammalian cells (13). In the present study we found
that noscapine did not significantly affect the in vitro
assembly of tubulin into microtubules even at concentrations as high as
100 µM. At such a high concentration, many other known microtubule inhibitors (e.g. paclitaxel, nocodazole,
colchicine, vinblastine, etc.) strongly promote or inhibit microtubule
assembly (6, 42). Our data further demonstrated that noscapine, as predicted from the in vitro microtubule behavior, did not
significantly change the tubulin polymer/monomer ratios in HeLa cells.
The minor effect of noscapine on microtubule assembly was also
predicted by the nature of its alteration of microtubule dynamics at
steady state in vitro. Microtubule growing and shortening
rates and their extents were both slightly inhibited by noscapine, and
the catastrophe frequency was reduced, resulting in an increased
attenuated phase. However, at the concentrations used for the above
studies, noscapine efficiently blocked cells in mitosis. Thus, these
findings clearly show that noscapine interacts with microtubules in a
manner distinct from many other microtubule drugs. These results also
support the hypothesis that the mechanisms by which anti-microtubule
drugs inhibit cell division and proliferation might lie in the
suppression of spindle microtubule dynamics (43).
Chemical compounds that suppress spindle dynamics without increasing or
decreasing microtubule polymer mass have been very powerful
agents in the direct testing of the roles of microtubule dynamics in
mitosis (6). Because these drugs affect microtubule assembly and
dynamics through diverse mechanisms, their use and action in the study
of mitosis collectively might provide invaluable information about the
role that microtubules play in the progression of mitosis. In this
study we have explored the use of noscapine in analyzing mitosis. The
finding that noscapine causes chromosome congression failure is very
intriguing. It is possible that suppression of microtubule dynamics by
noscapine might affect the chromosome-capturing ability of
microtubules, which is essential for chromosome congression and
subsequent alignment at the metaphase equator. Alternatively, the
interaction of noscapine with microtubules might influence the
interaction of microtubules with motor molecules that is required for
chromosome movement to the equatorial center (44, 45). It has been
demonstrated that chromosome congression is not a smooth, continuous
movement of chromosomes from the poles to the equatorial plate, but
rather it is a nonlinear journey involving frequent oscillations both
toward and away from the poles (32, 46-48). Such movements
would necessarily require frequent transitions between microtubule
growth and shortening. Thus, the most likely explanation is that the
inhibition of the microtubule catastrophe frequency by noscapine and
the increase in the fraction of time that the microtubules remain in
the attenuated state delay or prevent chromosome congression.
Physical tension across kinetochore pairs, another property closely
related to the dynamic instability of microtubules, is also thought to
be critical for chromosome movement during mitosis. Our results
demonstrate that alteration of microtubule dynamics by noscapine does
not cause major changes in spindle morphology, and yet the altered
dynamics results in the loss of kinetochore tension, as revealed by the
reduction of sister kinetochore distance. In addition, our preliminary
electron microscopic analysis shows that noscapine treatment also leads
to reduction in the number of kinetochore microtubules of the aligned
chromosomes.2 Thus, the loss of tension by noscapine
treatment can be attributed not only to the suppression of microtubule
dynamics but also to fewer microtubules attached per kinetochore. In
this study, we found that tension on the kinetochores of chromosomes
that failed to align at the equatorial mid-plate but rather remained
near the spindle poles was even less than that of chromosomes aligned at the metaphase equator. This is understandable because most of the
unaligned chromosomes might be mono-oriented without attaching to the
opposite spindle pole, whereas those that are aligned might associate
with microtubules from the two poles. These results are also consistent
with results obtained with substoichiometric nanomolar concentration of
vinblastine, which also dampens spindle microtubule dynamics without
perturbing bipolar spindle association with kinetochores (35, 36).
The goal of the cell division cycle is to produce two genetically
identical cells from one. To ensure fidelity in the transmission of
genetic information, the cell must be able to detect errors before
chromosome segregation at anaphase. This is achieved by the spindle
checkpoint, which prevents the onset of anaphase until all of the
chromosomes are correctly attached by spindle microtubules and proper
tension is applied to the chromosomes (33, 34). Our data show that the
spindle checkpoint proteins Mad2, Bub1, and BubR1 all respond, yet to
different degrees, to kinetochore-microtubule attachment and/or
tension. It will be of great importance to investigate further how the
attachment and/or tension signal the spindle checkpoint machinery as
well as how various checkpoint proteins participate in these processes.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Tim J. Yen, Edward D. Salmon,
and Kevin F. Sullivan for reagents, Eric Griffis for help in measuring
fluorescence intensity, and Hong Yi for superb technical assistance in
electron microscopy. We are greatly indebted to the anonymous reviewer for extremely helpful suggestions about experiments. We also thank Dr.
Maureen A. Powers for careful reading of our manuscript.
 |
FOOTNOTES |
*
This work was supported by grants from the National
Institutes of Health (to H. C. J. and L. W.) and the United States
Public Health Service (to D. P. and L. W.) and an award from
the Association for the Cure of the Prostate (to D. P. and L. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Dept. of Cell Biology,
Emory University School of Medicine, 1648 Pierce Dr., Atlanta, GA
30322. Tel.: 404-727-0445; Fax: 404-727-6256; E-mail: joshi@ cellbio.emory.edu.
Current address: Biotechnology Center, Indian Institute of
Technology, Bombay, Powai, Mumbai 400 076, India.
Published, JBC Papers in Press, February 25, 2002, DOI 10.1074/jbc.M110369200
2
J. Zhou and H. C. Joshi,
unpublished observation.
 |
ABBREVIATIONS |
The abbreviations used are:
BSA, bovine serum
albumin;
Pipes, 1,4-piperazinediethanesulfonic acid;
MES.
4-morpholineethanesulfonic acid, PBS, phosphate-buffered saline.
 |
REFERENCES |
| 1.
|
Nogales, E.
(2000)
Annu. Rev. Biochem.
69,
277-302[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Mitchison, T.,
and Kirschner, M.
(1984)
Nature
312,
237-242[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Mitchison, T.,
and Kirschner, M.
(1984)
Nature
312,
232-237[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Margolis, R. L.,
and Wilson, L.
(1978)
Cell
13,
1-8[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Walker, R. A.,
O'Brien, E. T.,
Pryer, N. K.,
Soboeiro, M. F.,
Voter, W. A.,
Erickson, H. P.,
and Salmon, E. D.
(1988)
J. Cell Biol.
107,
1437-1448[Abstract/Free Full Text]
|
| 6.
|
Jordan, M. A.,
and Wilson, L.
(1999)
Methods Cell Biol.
61,
267-295[Medline]
[Order article via Infotrieve]
|
| 7.
|
Joshi, H. C.
(1998)
Curr. Opin. Cell Biol.
10,
35-44[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Saxton, W. M.,
Stemple, D. L.,
Leslie, R. J.,
Salmon, E. D.,
Zavortink, M.,
and McIntosh, J. R.
(1984)
J. Cell Biol.
99,
2175-2186[Abstract/Free Full Text]
|
| 9.
|
Schulze, E.,
and Kirschner, M.
(1986)
J. Cell Biol.
102,
1020-1031[Abstract/Free Full Text]
|
| 10.
|
Pepperkok, R.,
Bre, M. H.,
Davoust, J.,
and Kreis, T. E.
(1990)
J. Cell Biol.
111,
3003-3012[Abstract/Free Full Text]
|
| 11.
|
Belmont, L. D.,
Hyman, A. A.,
Sawin, K. E.,
and Mitchison, T. J.
(1990)
Cell
62,
579-589[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Amon, A.
(1999)
Curr. Opin. Genet. Dev.
9,
69-75[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Ye, K., Ke, Y.,
Keshava, N.,
Shanks, J.,
Kapp, J. A.,
Tekmal, R. R.,
Petros, J.,
and Joshi, H. C.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
1601-1606[Abstract/Free Full Text]
|
| 14.
|
Toso, R. J.,
Jordan, M. A.,
Farrell, K. W.,
Matsumoto, B.,
and Wilson, L.
(1993)
Biochemistry
32,
1285-1293[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Panda, D.,
Daijo, J. E.,
Jordan, M. A.,
and Wilson, L.
(1995)
Biochemistry
34,
9921-9929[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Panda, D.,
Goode, B. L.,
Feinstein, S. C.,
and Wilson, L.
(1995)
Biochemistry
34,
11117-11127[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Panda, D.,
Miller, H. P.,
Banerjee, A.,
Luduena, R. F.,
and Wilson, L.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
11358-11362[Abstract/Free Full Text]
|
| 19.
|
Gildersleeve, R. F.,
Cross, A. R.,
Cullen, K. E.,
Fagen, A. P.,
and Williams, R. C.
(1992)
J. Biol. Chem.
267,
7995-8006[Abstract/Free Full Text]
|
| 20.
|
Joshi, H. C.,
and Cleveland, D. W.
(1989)
J. Cell Biol.
109,
663-673[Abstract/Free Full Text]
|
| 21.
|
Sambrook, J.,
Fritch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 22.
|
King, J. M.,
Hays, T. S.,
and Nicklas, R. B.
(2000)
J. Cell Biol.
151,
739-748[Abstract/Free Full Text]
|
| 23.
|
Hoffman, D. B.,
Pearson, C. G.,
Yen, T. J.,
Howell, B. J.,
and Salmon, E. D.
(2001)
Mol. Biol. Cell
12,
1995-2009[Abstract/Free Full Text]
|
| 24.
|
Waters, J. C.,
Skibbens, R. V.,
and Salmon, E. D.
(1996)
J. Cell Sci.
109,
2823-2831[Abstract]
|
| 25.
|
Dhamodharan, R.,
Jordan, M. A.,
Thrower, D.,
Wilson, L.,
and Wadsworth, P.
(1995)
Mol. Biol. Cell
6,
1215-1229[Abstract]
|
| 26.
|
Gliksman, N. R.,
Skibbens, R. V.,
and Salmon, E. D.
(1993)
Mol. Biol. Cell
4,
1035-1050[Abstract]
|
| 27.
|
Schaar, B. T.,
Chan, G. K. T.,
Maddox, P.,
Salmon, E. D.,
and Yen, T. J.
(1997)
J. Cell Biol.
139,
1373-1382[Abstract/Free Full Text]
|
| 28.
|
Chan, G. K. T.,
Schaar, B. T.,
and Yen, T. J.
(1998)
J. Cell Biol.
143,
49-63[Abstract/Free Full Text]
|
| 29.
|
Yao, X.,
Abrieu, A.,
Zheng, Y.,
Sullivan, K. F.,
and Cleveland, D. W.
(2000)
Nat. Cell Biol.
2,
484-491[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
McEwen, B. F.,
Chan, G. K. T.,
Zubrowski, B.,
Savoian, M. S.,
Sauer, M. T.,
and Yen, T. J.
(2001)
Mol. Biol. Cell
12,
2776-2789[Abstract/Free Full Text]
|
| 31.
|
Mitchison, T.,
Evans, L.,
Schulze, E.,
and Kirschner, M.
(1986)
Cell
45,
515-527[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Cassimeris, L.,
Rieder, C. L.,
and Salmon, E. D.
(1994)
J. Cell Sci.
107,
285-297[Abstract]
|
| 33.
|
Nicklas, R. B.
(1997)
Science
275,
632-637[Abstract/Free Full Text]
|
| 34.
|
Rieder, C. L.,
and Salmon, E. D.
(1998)
Trends Cell Biol.
8,
310-318[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Shelby, R. D.,
Hahn, K. M.,
and Sullivan, K. F.
(1996)
J. Cell Biol.
135,
545-557[Abstract/Free Full Text]
|
| 36.
|
Skoufias, D. A.,
Andreassen, P. R.,
Lacroix, F. B.,
Wilson, L.,
and Margolis, R. L.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
4492-4497[Abstract/Free Full Text]
|
| 37.
|
Li, Y.,
and Benezra, R.
(1996)
Science
274,
246-248[Abstract/Free Full Text]
|
| 38.
|
Cahill, D. P.,
Lengauer, C., Yu, J.,
Riggins, G. J.,
Willson, J. K. V.,
Markowitz, S. D.,
Kinzler, K. W.,
and Vogelstein, B.
(1998)
Nature
392,
300-303[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Taylor, S. S., Ha, E.,
and McKeon, F.
(1998)
J. Cell Biol.
142,
1-11[Abstract/Free Full Text]
|
| 40.
|
Chan, G. K. T.,
Jablonski, S. A.,
Sudakin, V.,
Hittle, J. C.,
and Yen, T. J.
(1999)
J. Cell Biol.
146,
941-954[Abstract/Free Full Text]
|
| 41.
|
Shah, J. V.,
and Cleveland, D. W.
(2000)
Cell
103,
997-1000[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Dustin, P.
(ed)
(1984)
Microtubules
, Springer-Verlag, New York
|
| 43.
|
Wilson, L.,
and Jordan, M. A.
(1995)
Chem. Biol.
2,
569-573[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Funabiki, H.,
and Murray, A. W.
(2000)
Cell
102,
411-424[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Antonio, C.,
Ferby, I.,
Wilhelm, H.,
Jones, M.,
Karsenti, E.,
Nebreda, A. R.,
and Vernos, I.
(2000)
Cell
102,
425-435[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Rieder, C. L.,
Davison, E. A.,
Jensen, L. C.,
Cassimeris, L.,
and Salmon, E. D.
(1986)
J. Cell Biol.
103,
581-591[Abstract/Free Full Text]
|
| 47.
|
Wise, D.,
Cassimeris, L.,
Rieder, C. L.,
Wadsworth, P.,
and Salmon, E. D.
(1991)
Cell Motil. Cytoskeleton
18,
131-142[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Ault, J. G.,
DeMarco, A. J.,
Salmon, E. D.,
and Rieder, C. L.
(1991)
J. Cell Sci.
99,
701-710[Abstract]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Mohan and D. Panda
Kinetic Stabilization of Microtubule Dynamics by Estramustine Is Associated with Tubulin Acetylation, Spindle Abnormalities, and Mitotic Arrest
Cancer Res.,
August 1, 2008;
68(15):
6181 - 6189.
[Abstract]
[Full Text]
[PDF]
|
 |
|